BioWorld

May 21, 2003

View Archived Issues

Inspire's Intranasal Drug Fails To Hit Endpoint In Allergic Rhinitis

Inspire Pharmaceuticals Inc. reported less-than-rousing results from a Phase III trial in allergic rhinitis. (BioWorld Today) Read More

Plexxikon Enters First Partnership, Signs Deal With Rising Genentech

Read More

EU Officials Call U.S. Complaint On GMOs 'Misguided, Unhelpful'

Read More

Supreme Court Sends Maine Lawsuit Back To District Court

Read More

Other News To Note

Read More